Latest Medtech News
Teleflex has completed the $1.5 billion sale of its OEM business to Montagu and Kohlberg, marking a key step in its transformation strategy and sharpening its focus on its core medical technology businesses.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
The company expects approximately $1.25 billion in after-tax proceeds, which it plans to use to reduce debt and repurchase shares. Teleflex said the divestiture enhances its financial flexibility, supporting future innovation, sustainable growth, and capital returns to shareholders, while allowing the OEM business to operate independently under its new owners.
“The close of the OEM transaction marks a pivotal milestone in Teleflex's transformation strategy, sharpening the Company's focus on the commercial excellence of its continuing businesses,” the company said.
